3LKA
Catalytic domain of human MMP-12 complexed with hydroxamic acid and paramethoxy-sulfonyl amide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SEALED TUBE |
Source details | OXFORD DIFFRACTION ENHANCE ULTRA |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2005-07-25 |
Detector | OXFORD ONYX CCD |
Wavelength(s) | 1.54056 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 51.566, 60.194, 54.215 |
Unit cell angles | 90.00, 115.09, 90.00 |
Refinement procedure
Resolution | 36.910 - 1.800 |
R-factor | 0.17258 |
Rwork | 0.169 |
R-free | 0.20996 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1y93 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | MOLREP |
Refinement software | REFMAC (5.0) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.090 | 1.900 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.062 | 0.218 |
Number of reflections | 12316 | |
<I/σ(I)> | 14.5 | 4.7 |
Completeness [%] | 88.5 | 38.1 |
Redundancy | 3.3 | 1.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 289 | 0.1 M Tris-HCl, 30% PEG 6000, 200 mM AHA, 1.0 M LiCl2, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K |